IP Group unveils new venture capital fund

IP Group, the developer of intellectual property-based businesses, has established a 30m-pound venture capital fund, IP Venture Fund II, in partnership with the European Investment Fund (the EIF).

IP Group, the developer of intellectual property-based businesses, has established a 30m-pound venture capital fund, IP Venture Fund II, in partnership with the European Investment Fund (the EIF).

The group said that IP Venture Fund II would be expected to invest alongside IP Group in new spin-out companies from IP Group's university partnerships and other collaborations, with the EIF effectively investing alongside IP Group.

The fund comprises £30m of capital with a £20m contribution from the EIF and a £10m contribution from IP Group.

It is expected to co-invest with IP Group in such ratio that the effective investment ratio between IP Group and the EIF will be four:one when considering that IP Group will also directly provide capital to companies alongside the fund, the group added.

Alan Aubrey, Chief Executive Officer of IP Group, said: "We are delighted to have agreed a second fund with the EIF; a key partner for the group who share a similar view on the importance of providing long-term patient capital to intellectual property commercialisation."

Piyush Unalkat, Principal of Equity Investments at the EIF, said: "We have been working with IP Group since 2006 and have been impressed by the group's ability to build valuable companies from the best of British intellectual property and evidence returns to co-investors and shareholders. We look forward to creating the next generation of spin-outs with the new Fund."

IP Group's share price was down 2.44% to 136.10p at 09:32 on Thursday.

MF

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022